323 related articles for article (PubMed ID: 2062847)
1. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
[TBL] [Abstract][Full Text] [Related]
2. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
McKeating J; Balfe P; Clapham P; Weiss RA
J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202
[TBL] [Abstract][Full Text] [Related]
3. A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera.
Ghetie V; Wheeler T; Scott D; Uhr JW; Vitetta ES
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1945-8. PubMed ID: 1489581
[TBL] [Abstract][Full Text] [Related]
4. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
Batinić D; Robey FA
J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
6. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
Bachelder RE; Bilancieri J; Lin W; Letvin NL
J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4.
Werner A; Levy JA
J Virol; 1993 May; 67(5):2566-74. PubMed ID: 8474162
[TBL] [Abstract][Full Text] [Related]
8. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
[TBL] [Abstract][Full Text] [Related]
9. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
Harrop HA; Rider CC
Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
[TBL] [Abstract][Full Text] [Related]
10. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
12. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies.
Kaiser PK; Offermann JT; Lipton SA
Neurology; 1990 Nov; 40(11):1757-61. PubMed ID: 2234433
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
[TBL] [Abstract][Full Text] [Related]
14. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 region.
Kröpelin M; Süsal C; Daniel V; Opelz G
Immunol Lett; 1998 Aug; 63(1):19-25. PubMed ID: 9719434
[TBL] [Abstract][Full Text] [Related]
16. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.
Kang CY; Nara P; Chamat S; Caralli V; Ryskamp T; Haigwood N; Newman R; Köhler H
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6171-5. PubMed ID: 2068099
[TBL] [Abstract][Full Text] [Related]
17. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
Corbeau P; Haran M; Binz H; Devaux C
Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
[TBL] [Abstract][Full Text] [Related]
18. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
[TBL] [Abstract][Full Text] [Related]
19. Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120.
Arvinte T; Schulz B; Madoulet C; Nicolau C
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1041-5. PubMed ID: 1698964
[TBL] [Abstract][Full Text] [Related]
20. Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia.
Karpatkin S; Nardi MA; Kouri YH
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1487-91. PubMed ID: 1741404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
